Levobupivacaine Hydrochloride

盐酸左布比卡因

Report date: 2026/03/10 20:00:16
NME

Base Information

Drug NameLevobupivacaine Hydrochloride
Drug Alias Namelevobupivacaina盐酸左旋布比卡因(S)-bupivacainelevobupivacainumPopscaine +[8] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel alpha subunit blockers
TargetsSodium channel alpha subunit
Therapy Area/IndicationsPain, PostoperativeHernia, InguinalBrachial Plexus Neuropathies +[7] 
Global Approved IndicationsAnesthesia
Approved Indications in ChinaAnesthesia
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesEgyptFrance +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPurdue Pharma
China Registration ClassN/A

Develop Information

Active CompaniesEgymedicalpediaInstituto De Investigación Sanitaria AragónSouth Egypt Cancer Institute +[7] 
Inactive CompaniesPurdue PharmaAssiut University
Active IndicationsPain, PostoperativeHernia, InguinalBrachial Plexus Neuropathies +[6] 
Inactive IndicationsPeripheral Nervous System Diseases

Other Information

ATC CodeN01BB10
Related LinksWikipediaDrugBankKEGG